Discovery of 2-aminothiazole-4-carboxylic acids as broad-spectrum metallo-β-lactamase inhibitors by mimicking carbapenem hydrolysate binding

YH Yan, TT Zhang, R Li, SY Wang, LL Wei… - Journal of Medicinal …, 2023 - ACS Publications
Metallo-β-lactamases (MBLs) are zinc-dependent enzymes capable of hydrolyzing all
bicyclic β-lactam antibiotics, posing a great threat to public health. However, there are …

[HTML][HTML] New Delhi Metallo-Beta-Lactamase Inhibitors: A Systematic Scoping Review

L Nahar, H Hagiya, K Gotoh, M Asaduzzaman… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Among various carbapenemases, New Delhi metallo-beta-
lactamases (NDMs) are recognized as the most powerful type capable of hydrolyzing all …

[HTML][HTML] Novel combination of nanoparticles and metallo-β-lactamase inhibitor/antimicrobial-based formulation to combat antibiotic resistant Enterococcus sp. and …

NC Gómez, J Manetsberger, N Benomar… - International Journal of …, 2023 - Elsevier
Nanotechnology presents an innovative strategy to combat the spread of antibiotic resistant
bacteria and their resistance genes throughout different ecosystems. To address this …

α-Aminophosphonate inhibitors of metallo-β-lactamases NDM-1 and VIM-2

K Palica, F Deufel, S Skagseth… - RSC Medicinal …, 2023 - pubs.rsc.org
The upswing of antibiotic resistance is an escalating threat to human health. Resistance
mediated by bacterial metallo-β-lactamases is of particular concern as these enzymes …

Distinct Inhibition Modes of New Delhi Metallo-β-lactamase-1 Revealed by NMR Spectroscopy

K Cheng, Q Wu, C Yao, Z Chai, L Jiang, M Liu, C Li - JACS Au, 2023 - ACS Publications
The wide spread of antibiotic-resistant “superbugs” containing New Delhi metallo-β-
lactamase-1 (NDM-1) has become a threat to human health. However, clinically valid …

[HTML][HTML] Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose

A Kondratieva, K Palica, C Frøhlich, RR Hovd… - European Journal of …, 2024 - Elsevier
Bacterial resistance to the majority of clinically used β-lactam antibiotics is a global health
threat and, consequently, the driving force for the development of metallo-β-lactamase …

Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1)

Z Bibi, I Asghar, NM Ashraf, I Zeb, U Rashid, A Hamid… - Pharmaceuticals, 2023 - mdpi.com
The effectiveness of all antibiotics in the β-lactam group to cure bacterial infections has been
impaired by the introduction of the New Delhi Metallo-β-lactamase (NDM-1) enzyme …

Metallo-β-lactamases

E Denakpo, G Arlet, A Philippon, BI Iorga - Metalloenzymes, 2024 - Elsevier
Abstract Metallo-β-lactamases (MBLs) are a class of enzymes that are produced by a variety
of bacterial species and are responsible for conferring resistance to a broad range of β …

[HTML][HTML] A computational exploration of whole genome sequences of Klebsiella pneumoniae ST16 for beta-lactam resistance and the discovery of NDM-1 resistance …

TA Ibisanmi, CB Olowosoke, TO Ayeni… - Informatics in Medicine …, 2024 - Elsevier
Antibiotic resistance is a growing concern in healthcare and medicine. This research was
carried out to analyze whole genome sequences of Klebsiella pneumoniae ST16 with the …

Rational design of novel compounds to serve as potential NDM-1 inhibitors using molecular docking, molecular dynamics simulation, and physicochemical studies

T Salih, PG Ali - Molecular Simulation, 2023 - Taylor & Francis
ABSTRACT New Delhi Metallo-β-lactamase (NDM-1) is an enzyme that hydrolyses a wide
range of β-lactam antibiotics, including most carbapenems, leading to antimicrobial …